The Daily Item
WILLIAMSPORT — A Northumberland woman has joined more than 200 people nationwide who have filed suit against Pfizer Inc. alleging users of Lipitor were not warned use of the drug could lead to type 2 diabetes in females.
Bonnie S. Gordon this week filed suit in U.S. Middle District Court as did Candace Hess of Orangeville. The women are represented by the same law firm.
The suits accuse Pfizer of promoting and marketing Lipitor, a drug prescribed to reduce the amount of cholesterol and other fatty substances in the blood, as being safe for people like Gordon.
In February 2012, Pfizer added a warning label of the potential relationship between changes in blood sugar levels.
Gordon, according to the court complaint, was prescribed Lipitor in 2004 when she was 60 as a preventive measure to decrease her risk of developing cardiovascular disease. Last May she was diagnosed with type 2 diabetes, the document states.
The Hess complaint states she began taking Lipitor in 2008 and was diagnosed with diabetes four years later.
Gordon has developed occasional dizziness, blurred vision, numbness in the feet and has a markedly increase risk of heart disease, neuropathy and blindness, the suit states.
Had she known the risks of the taking Lipitor, she said she either would not have taken the drug or closely monitored her blood glucose levels.
Gordon accuses Pfizer of negligence, negligent representation, fraud and violations of the Pennsylvania Unfair Trade Practices and Consumer Protection Law.
She is seeking unspecified compensatory and punitive damages, payment of her medical expenses and a full refund of what she paid for Lipitor.